HORSHAM, England--(BUSINESS WIRE)--Cmed Group, a full service CRO that specialises in complex early phase trials, announces it has entered into a strategic partnership with a top 5 pharmaceutical company to provide data capture and management services to support their early phase (phase I, II, Proof of Concept) clinical trial pipeline. Under the three year agreement, Cmed, which has a strong pedigree in data capture and management using its innovative proprietary technologies, will also collaborate on process and technology innovations to further improve and speed data visibility for critical decision making, while achieving cost efficiencies and high quality.
This agreement cements a closer partnership in which Cmed has provided data and biometric services to their client for over 12 years.
Dr. David Connelly, Cmed CEO commented “One of the key drivers for our client was the need for a responsive partner to provide flexible, high quality, efficient services for their fast paced, high throughput early phase pipeline. Cmed has consistently demonstrated, over many years, to be leaders in combining data management services and technology, even in the most complex trials. We are therefore delighted our client chose Cmed to form a strategic partnership so we can develop an already effective and efficient collaboration managing clinical data from our early phase trials into something that is truly smart and world class”.
Dr. Connelly went on to add “we are proud they have put their trust in us and they have chosen Cmed as a significant partner to help achieve this vision, and to support their burgeoning and exciting pipeline of potential new treatments. We are confident that together, with our existing and emerging technologies and approaches, we can transform the setup, collection, management and review of clinical trial data”.
For further information about Cmed’s biometrics functional services visit www.cmedresearch.com or book an appointment with a Cmed representative at the forthcoming ACDM Annual Conference (9-11 March, De Vere Wokefield Park, Reading, UK) at info@cmedresearch.com. Cmed will also be presenting on day two of the event about mobile technology in clinical trials.
- ends-
About Cmed Group (www.CmedGroup.com)
Cmed Group is an innovative clinical trials services and advanced software provider which includes two divisions: Cmed Clinical Services and Cmed Technology.
Cmed Clinical Services (www.CmedResearch.com) is a CRO that provides full service trial delivery teams (project management, clinical monitoring, data management, biostatistics, medical affairs, regulatory, consulting, and medical writing services) as well as stand-alone solutions across all its services, including Biometrics functional services. It combines experience with using many commercially available technologies but also uses trusted and innovative software developed by Cmed Technology, including its award winning system, Timaeus.
Cmed Technology, (www.CmedTechnology.com) offers Timaeus: a single platform for electronic trial design, paper and electronic data capture, monitoring, coding, data management and reporting. Timaeus, which uses advanced distributed cloud computing and mobile technologies, is designed to respond on-demand to the needs of investigators, data managers and study teams. Timaeus has been used in every phase of clinical research – including early phase, pivotal and late phase studies as well as in emerging markets.
